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Abstract 
Sleep in Pediatric Sickle Cell Disease 
Lauren C. Daniel 
Lamia P. Barakat, Ph.D. 
 
 
 
 
Background:  Children with sickle cell disease (SCD) are at an increased risk for sleep 
disorders as compared to healthy controls possibly due to disease processes, pain, 
minority status, and living in an urban environment.  Research to date has focused on the 
increased occurrence of specific sleep disorders (i.e., sleep-disordered breathing, 
hypoxemia, nocturnal enuresis) in this population, but no research exists describing 
general sleep behaviors and disorders of children with SCD.  Sleep is an important factor 
in typical development and health maintenance but the role it plays in SCD is unclear.   
Method:  The current study described the occurrence of sleep problems in 4-10 year old 
children with SCD (N = 54) as compared to an urban control group (N = 52) and created 
preliminary normative values for a commonly used screening device for sleep disorders, 
the Children’s Sleep Habits Questionnaire (CSHQ; Owens, Spirito, and McGuinn, 2000), 
in children with SCD.  With alpha set at .05 and a medium effect size, the power for the 
current study is .70 for t-tests and .60 for regressions.  The hemoglobinopathies 
represented in the sample are HBSS (n = 28), HBSC (n = 22), HBSβ+ Thalassemia (n = 
1), HBSβo Thalassemia (n = 2), and S other (n = 1).  It was hypothesized that parents of 
children with SCD would report greater rates of sleep concerns than parents of healthy 
children.  Also, it was also hypothesized that disease severity and socioeconomic status 
would be significant predictors of the number of sleep concerns endorsed for children 
with SCD.     
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Results:  Parents of children with SCD reported significantly more behaviors associated 
with night waking, sleep-disordered breathing, and enuresis than parents of children in 
the SES-matched control group.  Parents of children with SCD reported significantly 
more behaviors associated with bedtime resistance, sleep onset delay, sleep duration, 
sleep anxiety, night waking, parasomnias, sleep-disordered breathing, and daytime 
sleepiness than the CSHQ validation sample.  Within the SCD group, percent of 
individuals living in poverty in the child’s zip code was related to responses on the 
Parasomnia and Sleep-disordered Breathing subscale and Total Sleep Problems reported.  
Healthcare utilization was significantly related to the Parasomnia subscale and SCD 
Complications score was related to the Parasomnia and Sleep-disordered Breathing 
subscale and Total Sleep Problems reported.  Children with more severe genotypes were 
reported to exhibit significantly more enuresis and Parasomnia subscale behaviors.  A 
regression predicting parent reported Parasomnias using the predictors genotype, SCD 
complications, Healthcare Utilization, and Percent in Poverty accounted for 39.0% of the 
variance.  The same predictors accounted for 20.7% of the variance in Total Sleep 
Problems and 21.3% of the variance in Sleep-disordered Breathing. 
Conclusions:  There are several limitations to this study that may have affected the 
results, including small sample size, biased information in medical charts, and low alphas 
for some subscales.  The results indicate the importance of routinely assessing sleep in 
children with SCD, as they are more likely to exhibit disrupted overnight sleep than other 
children their age and of similar demographics.  Further research assessing the 
relationship between poor sleep quality and pain episodes is necessary using objective 
and subjective measures.  Additionally, given the significantly higher rates of parent 
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reported sleep-disordered breathing and night waking in this population it is important to 
consider interventions to minimize these disruptions to overnight sleep.    
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I.  Introduction 
Little is known about the sleep of children with Sickle Cell Disease (SCD).  The 
few studies addressing this issue have focused on the increased occurrence of sleep-
disordered breathing (Samuels, Stebbens, Davies, Picton-Jones, & Southall, 1992) and 
nocturnal hypoxemia in this population (Hargrave, Wade, Evans, Hewes, & Kirkham, 
2003; Needleman et al., 1999) or the disruption of sleep during pain episodes (Jacob et 
al., 2006; Palermo & Kiska, 2005).  Few studies exist focusing on the general sleep habits 
of children with SCD or on the incidence of abnormalities in sleep of this population.  
Because of the chronic nature of SCD, it is important to understand the bi-directional 
relationship of sleep and the disease course.   
Sleep disruption has been demonstrated in other pediatric chronic illnesses, such 
as human immunodeficiency virus, juvenile rheumatoid arthritis, and asthma (Franck et 
al., 1999; Labyak, Bourguignon, & Docherty, 2003; Sadeh et al., 1998).  Human 
immunodeficiency virus is thought to affect children in much the same way it does 
adults, causing increased and longer night wakings, shorter sleep duration, and increased 
daytime tiredness as compared to non-infected controls (Franck et al.).   Asthma worsens 
during sleep due to several factors such as decreased lung volume and increased airway 
resistance (for a review see Bandla & Splaingard, 2004).  Thus, the nocturnal worsening 
of asthma symptoms disrupts sleep.  Children with asthma demonstrate shorter sleep 
times, increased night wakings, and a reduction in stage N-3 sleep, all of which are 
correlated with asthma severity (Sadeh et al.).  The exact cause of these sleep disruptions 
is unknown.  Juvenile rheumatoid arthritis can result in frequent night wakings, sleep 
apnea, excessive daytime sleepiness, increased nighttime movements, and fatigue (see 
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Labyak, Bourguignnon, & Docherty for a review).  It is unclear whether the sleep 
disturbances are caused by disease processes or the significant pain that these children 
and adolescents experience (Lewin & Dahl, 1999).  Little research exists exploring what 
these changes in sleep may mean for development, quality of life, and the disease course 
in these children.   
The exact mechanisms of the relationship between chronic illness and sleep 
disturbances are unknown and under studied (NHLBI, 2003), though there are 
documented disruptions in the composition of sleep stages known as sleep architecture 
(Sadeh et al., 1998), fatigue (Franck et al., 1999), and daytime sleepiness (Labyak et al., 
2003) in many chronic illnesses.  Disruptions in sleep may occur in children with SCD as 
a result of similar mechanisms identified for other chronic conditions of childhood.  If 
pain is responsible for sleep disturbances in juvenile rheumatoid arthritis (Labyak et al.), 
similar disturbances may exist in SCD.  As seen in asthma (Sadeh et al.), nocturnal 
reductions in air flow and hypoxemia could also be a possible explanation of sleep 
disturbances in SCD.  The bi-directional relationship between weakened immune systems 
and sleep demonstrated in children with the human immunodeficiency virus (Franck et 
al.) may also play a role in sleep abnormalities in children with SCD.   
Because SCD is a chronic disease that can be affected by environmental, health, 
and behavioral factors, understanding the impact of the disease on sleep is important to 
maximizing quality of life in these children (Figure 1).  If the disease causes poor sleep 
quality, then children may be at risk for a host of developmental and psychosocial 
problems, beyond those caused by SCD, as a result of inadequate sleep.  Also, poor sleep 
may affect the disease course, thus exacerbating symptoms.  The purpose of this study is 
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to describe the incidence of sleep problems in a population of children with SCD by 
using parent reports of sleep behaviors in 4 to 10 year old children with SCD as 
compared to an ethnically and socio-economically matched control group of children.  A 
current review of the literature will focus on symptoms and treatment of SCD.  Next, risk 
factors for sleep concerns in SCD will be examined, specifically disease related 
complications and symptoms and their impact on sleep.  Lastly, environmental factors 
such as socioeconomic status, ethnic minority status, and urban living and their 
contribution to sleep in children with SCD will be reviewed.     
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II. Literature Review 
Background of Sickle Cell Disease 
 Sickle cell disease is most prevalent among those of African descent, but it also 
occurs in those with Mediterranean, Caribbean, South American, Middle Eastern, and 
East Indian heritage (U.S. Department of Health and Human Services, 1993).  The 
presence of the HB S gene is protective against infection by the parasite responsible for 
malaria (Ashley-Koch, Yang, & Olney, 2000).  Because of the protective nature of HB S, 
this genetic variation is more common in individuals from areas with a high occurrence 
of malaria.  The prevalence of SCD in African American births is 1 in 375 for HBSS, 1 in 
835 for HBSC disease, and 1 in 1,667 for HBSβ Thalassemia (U.S. Department of Health 
and Human Services).  Currently, SCD is estimated to affect 70,000 Americans, with 
approximately 1 in 12 African Americans carrying the HB S gene (sickle cell trait; 
NHLBI, 2007). 
Sickle cell disease refers to the presence of a variation in the beta globin gene 
(HB S), an integral part of hemoglobin (Ashley-Koch et al., 2000).  The homozygotic 
combination of this variation (HBSS) produces sickle cell anemia, the most severe form 
of SCD (Ashley-Koch et al.).  There are 5 other major heterozygotic combinations that 
result in SCD (Stuart & Nagel, 2005). The beta globin gene variation causes the 
production of hemoglobin, that when deoxygenated, changes shape from the natural 
donut shape to a sickle shape.  Because of the unusual shape and rigid nature as well as 
their likelihood to adhere to blood vessel walls, these deoxygenated hemoglobin are more 
likely to block blood flow (Ashle-Koch et al.).  The sickle shaped red blood cells are able 
to return to the normal disc shape in the presence of oxygen for a short period of time.  
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The shape changes result in permanent damage causing hemolysis, which is responsible 
for anemia and other complications (U.S. Department of Health and Human Services, 
1993).   
 The sickle shaped red blood cells can partially or completely occlude blood flow, 
and in turn oxygen, to any part of the body, resulting in tissue and organ damage 
(NHLBI, 1995).  These vaso-occlusive events usually cause severe pain for the patient, 
varying in length from one day to weeks of chronic pain (Dampier et al., 2004; Lemanek, 
Ranalli, Green, Biega, & Lupia, 2003).  A recent study found that 51% of pain episodes 
lasted one day or less in a population of children and adolescents, with severe pain 
reported for 12% of all pain days (Dampier et al.).   
Another possible effect of SCD is anemia, a state in which the patient has a lower 
red blood cell count than normal, which is responsible for fatigue, jaundice, and shortness 
of breath (NHLBI, 2007).   Other complications of SCD are acute chest syndrome, stroke, 
priapism, damage to the spleen and kidneys, short stature, delayed puberty, and gallstones 
(U.S. Department of Health and Human Services, 1993).  Damage to the spleen begins in 
infancy for patients with SCD, making the child extremely susceptible to infection (U.S. 
Department of Health and Human Services).   
Psychosocial problems can occur more often in children with SCD due to several 
factors beyond the disease process such as the genetic/inherited nature of SCD, shortened 
lifespan, and ethnic minority status (Barakat, Lash, Lutz, & Nicolaou, 2006).  Delayed 
development, chronic fatigue, and learning disabilities may also serve to alter 
relationships of children with SCD and peers (Noll et al., 1996).  Previous research is 
mixed regarding the rates of externalizing symptoms, internalizing symptoms, and social 
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competence, though findings regarding limitations of quality of life of children with SCD 
are consistent (see Barakat et al., 2006 for a review).  Because there are so many risk 
factors for developing psychosocial problems, even in the absence of a diagnosis of a 
specific mental health disorder, there may be an increased rate of sub-threshold 
depression and anxiety among this population.     
Treatment for Sickle Cell Disease Complications  
Because of the unpredictable nature of vaso-occulsive episodes that define SCD, 
some treatment is preventative, but the majority of treatment for sickle cell is palliative in 
nature (Ballas, 2002).  Approximately 90% of pain episodes are managed in the home, in 
part, to improve the quality of life of those with sickle cell (Shapiro et al., 1995).  
Treatments for pain episodes include non-pharmacological means such as: cutaneous 
stimulation (electric, heat, cold, or vibration stimulation of the site of pain), massage, 
guided imagery, distraction, relaxation, self-hypnosis, self-motivation, acupuncture, and 
biofeedback (Ballas).   
Pharmacological interventions for SCD pain are nonsteroidal anti-inflammatory 
drugs, opioids, and adjuvant medications, which are used to increase the relief of opioids 
and reduce their side effects (NHLBI, 2007).  A pain dairy study in children ages 6 to 21 
years of age (N = 37) found that children use physical and cognitive-behavioral strategies 
for managing pain such as sleeping, watching television, relaxation, or talking with others 
on 84.6% of pain days and analgesics on 77% of pain days (Dampier, Ely, Eggleston, 
Brodecki, & O’Neal, 2004).  Opioids are reserved for more severe pain partially because 
of their side effect profile (nausea, vomiting, respiratory depression, itching, and possible 
seizures) and sedating effect (Ballas, 2002).  Mild to moderate pain can be treated with 
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nonsteroidal anti-inflammatory drugs, acetaminophen, topical agents, and corticosteroids 
(Ballas), though these drugs have ceiling effects (NHLBI).   Nonsteroidal anti-
inflammatory drugs are related to renal failure and acetaminophen can cause liver 
damage, making the monitoring of dose and frequency crucial (NHLBI).   
Pain management often begins with nonsteroidal anti-inflammatory drugs and 
hydration, followed by a change to opioids if further pain relief is necessary (Lemanek et 
al., 2003).  These techniques can be used in conjunction with other non-pharmacological 
pain relief methods mentioned above for maximum benefit.  Chronic pain can be 
managed pharmacologically with long-acting opioids taken regularly and fast-acting 
opioids for the treatment of breakthrough pain (Ballas, 2002).  Currently, there are no 
data examining this form of treatment in children with SCD (Ballas). 
Blood transfusions are the most common option to control the risk of stroke and 
acute chest syndrome, improve anemia, and reduce severe chronic pain (Lemanek et al., 
2003).    Hydroxyurea can be used to reduce the number of pain episodes and risks for 
acute chest syndrome (Amrolia, Almeida, Davies, & Roberts, 2003), but it remains 
experimental in children.  The only curative measure to date is bone marrow 
transplantation (Amrolia et al.), though due to difficulties finding a matching donor and 
high mortality rates for this procedure (approximately 5-20%), it is rarely used (Lemanek 
et al., 2003).   
Recommendations for patients with sickle cell to prevent pain episodes are to eat 
balanced meals, take folic acid, take prophylactic antibiotics, drink adequate fluids, avoid 
extreme temperatures, exercise but be cautious of over-exertion, get enough sleep, limit 
alcohol, and not smoke (NHLBI, 2007).  Interventions to date have focused on the 
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importance of health maintenance in research on the control of pain in children with SCD 
(Chen, Cole, & Kato, 2004) and although sleep can be important to general health 
maintenance, its role in SCD is unknown.   
 
Sleep Concerns in Sickle Cell Disease 
 There are a number of possible sleep concerns that are a result of the disease 
process of SCD.  First, hypoxemia and high rates of sleep-disordered breathing can 
contribute to nightly sleep disruptions, affecting the child’s sleep and daytime 
functioning.  Second, disrupted overnight sleep due to pain, hypoxemia, and enuresis may 
also result in increased daytime tiredness.  Constant disruptions can lead to reduced sleep 
quality and quantity, which is related to externalizing behavior problems (Lavigne et al., 
1999), academic problems, symptoms of depression (Smaldone, Honig, & Byrne, 2007), 
and reduced cognitive performance (Buckhalt, El Shiki, & Keller, 2007), making sleep 
disruptions a significant concern in children with SCD.   
Hypoxemia 
 
 Children with SCD exhibit nocturnal oxyhemoglobin desaturation significantly 
more often than healthy controls, with rates demonstrated as high as 40% (Franco et al., 
1996).  Oxyhemoglobin levels can decrease substantially in children with SCD as 
compared to healthy controls (Samuels, Stebbens, Davies, Picton-Jones, & Southall, 
1993) and the amount of desaturation is related to the severity of SCD as assessed by 
comparing children with HBSS to children with HBSC and healthy controls (Setty, 
Stuart, Dampier, Brodecki, & Allen, 2003).  In addition, patients with sickle cell anemia 
(HBSS) have lower hemoglobin saturations during the day resulting in lower levels of 
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oxygen in the blood (Rackoff, Kunkel, Silber, Asakura, & Ohene-Frempong, 1993).  
Hypoxemia may be a result of either obstructive sleep apnea (OSA) due to adenotonsillar 
hypertrophy or in rare cases, chronic lung disease linked to SCD (Bandla & Splaingard, 
2004).  
Nocturnal desaturation may result in increased occurrences of vaso-occlusive 
episodes (Hargrave et al. 2003) and/or stroke (Kirkham et al., 2001).  In a study of 95 
children with SCD, pain episodes as measured by hospital admittance were highly 
correlated with hypoxemia recorded by pulse oximetry during polysomnography 
(Hargrave et al.).   Patients with low nocturnal oxygen saturation had significantly more 
pain episodes than those not demonstrating hypoxemia.  Dips in oxyhemoglobin 
saturation of 4% below baseline, were significantly associated with an average of 2.97 
more days of pain per year.  Decreased nocturnal oxyhemoglobin saturation may instigate 
pain because of the effects of desaturation on bone marrow leading to vaso-occlusive 
episodes (Hargrave et al.) or because of an increased tendency for adhesion of red blood 
cells to the endothelial cells in children with greater oxyhemoglobin desaturation (Setty et 
al., 2003).  In another report based on the same 95 patients, Kirkham and colleagues 
(2001) found nocturnal hemoglobin saturation and arterial velocity to be predictive of the 
time until central nervous system events.  Cerebrovascular disease caused by hypoxemia, 
a reduction in the threshold for infarction, or a combination of the two may be the 
mechanism between sleep-disordered breathing and stroke (Kirkham et al.).  Not all 
research, however, supports the relationship between hypoxemia and SCD severity.  In a 
study of 19 children with a range of sickle cell severity from mild to severe, based on the 
number of pain episodes experienced, there were no differences in sleep architecture or 
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nocturnal desaturations between the severe (patients hospitalized two times during the 
previous year) and mild (no hospitalizations in the previous year) cases of SCD (Brooks, 
Koziol, Chiarucci, & Berman, 1996).   
Sleep-Disordered Breathing 
Sleep-disordered breathing refers to the category of disorders of abnormal 
respiration during the night, either based on ventilation patterns or quantity of ventilation 
throughout the night (NHLBI, 2003).  Obstructive sleep apnea is the most common of 
these disorders, resulting in a collapse of the upper airway, which restricts airflow and 
results in hypoxia, disruptions in sleep, hypercapnia, and reductions in neurocognitive 
performance (NHLBI).  One of the most common symptoms of upper airway resistance 
that is responsible for sleep-disordered breathing is snoring, which is estimated to occur 
in 7-13% of healthy children ages 2-8 and 3-5% of older children (NHLBI).   In children, 
sleep-disordered breathing has been shown to be responsible for behavioral problems, 
learning difficulties, pulmonary hypertension, arterial hypertension, nocturnal enuresis, 
and reductions in growth (NHLBI).   
Based on clinical assessment, 55% of patients with HBSS and HBSβo 
Thalassemia (29 out of 53) demonstrated symptoms of sleep-disordered breathing 
(Samuels et al., 1993).  Fifty children of the original cohort opted for further specialist 
evaluation, which determined that 18 patients demonstrated upper airway obstruction that 
could contribute to sleep-disordered breathing.  A study of 65 patients with sickle cell 
anemia compared with 102 sibling controls found that children with sickle cell snored 
significantly more often than siblings (43% of HBSS versus 18% of controls) and that 
snoring children, regardless of sickle cell status, were more likely exhibit daytime 
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sleepiness (Wittig, Roth, Keenum, & Sarnaik, 1988).  This study only used parent report 
questionnaires and assumed that snoring served as a proxy for sleep-disordered breathing.   
Polysomnographies were conducted with 19 children with SCD, ages 2-19, 
exhibiting sleep-disordered breathing according to parent reports of snoring and irregular 
nighttime breathing (Kaleyias et al., 2008).  The data from the SCD group were 
compared to 14 healthy children with unremarkable polysomnographies.  Twelve 
children were diagnosed with obstructive sleep apnea and three were given the diagnosis 
of upper airway resistance syndrome.  The SCD group as a whole demonstrated 
significantly greater nocturnal desaturation than controls.   Children with SCD and sleep 
apnea were four times as likely to experience oxygen desaturation below 85% as 
compared to children with SCD and no obstructive sleep apnea.  One explanation of 
higher rates of sleep-disordered breathing may be a result of increased infections during 
childhood as a result of spleen damage leading to enlarged tonsils and adenoids, which 
may block airflow (Wittig et al., 1988).  Given the increased occurrence of sleep-
disordered breathing in SCD, these changes in nocturnal respiration could also account 
for nocturnal hypoxemia. 
Pain 
 The effects of pain on sleep are also a significant concern with both acute and 
chronic pain in SCD.  In a meta-analysis of pain literature related to medical conditions, 
most conditions associated with pain have been shown to reduce sleep efficiency, slow 
wave sleep, and rapid eye movement sleep (Onen, Onen, Courpron, & Dubray, 2005).  
Pain can be a frequent occurrence for children and adolescents with SCD as reported in 
pain diary studies.  One such study followed 37 children ages 5 to 19 years of age over 
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the course of 1 to 3 years (Dampier, Ely, Brodecki, & O’Neal, 2002).  Children reported 
514 distinct pain episodes over 18,377 diary days with pain occurring on 2,592 days and 
2,326 nights.  Another pain diary study that also collected sleep diaries two times a day 
for an average of 10 months, reported that children and adolescents’ (N = 18) sleep 
quality was affected by SCD pain (which occurred 30% of the days studied), with 
children rating sleep quality as poor on 43% of days with pain, as compared with 3% of 
days without pain (Shapiro et al., 1995).  In this study, sleep duration was also 
significantly shorter during pain episodes. 
 Valrie, Gil, Redding-Lallinger, and Daeschner (2007b; 2008) examined the 
relationship between sleep and pain in 20 8 –12-year-old children by using daily sleep 
and pain diaries and reports of mood and stress for up to 8 weeks.  The children reported 
pain on 21.31% of days during the course of the study, and the average pain rating on 
days with pain was 49.83 (on a 0-100 visual analog scale).  A multiple regression was 
conducted to predict child reported sleep quality from pain severity and stress controlling 
for age, gender, SCD type, and caregiver education.   The interaction between stress and 
pain severity created a model that accounted for 71.71% of the variance in sleep quality, 
indicating that younger female patients with HBSS and greater pain severity were more 
likely to have poor sleep quality (Valrie et al., 2007b).  Further analyses indicated that 
children experiencing greater stress had a stronger negative relationship between pain 
intensity and sleep quality.  Negative mood was also found to partially mediate the 
relationship between high pain and poor sleep quality during the night and the following 
day (Valrie et al., 2008).  Also, as participant moods became more positive, the strength 
of the pain and sleep quality relationship the following day decreased.    
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Another study utilizing pain and sleep diaries in 20 adolescents found a cyclical 
relationship between pain and sleep quality, with poor sleep preceding days with pain and 
days with pain being followed by poor sleep (Valrie et al., 2007b).  The combination of 
high pain and analgesics in this sample reduced the negative effects of pain on sleep 
quality.   This sample also reported pain on 22% of the days during the course of the 
study, therefore indicating marked and frequent disturbances of sleep.  A study of 86 
adolescents with a variety of chronic pain conditions (headache, juvenile idiopathic 
arthritis, and SCD) demonstrated a low but significant correlation between pain 
frequency and daytime sleepiness, also teens with longer pain episodes had later bedtimes 
(Palermo & Kiska, 2005).  These data were based on retrospective self-reports of sleep 
and pain.  When broken down across the three conditions, teens with sickle cell reported 
significantly less daytime sleepiness than teens with headaches.  There were no 
significant differences between the teens with arthritis and the other two groups.     
It is unclear whether changes in sleep architecture are due to medications taken 
for pain, disease processes, discomfort, lowered pain threshold (Onen et al., 2004), or a 
heightened arousal to bodily sensations keeping the individual from deeper stages of 
sleep (for a review of pain in children and sleep see Lewin & Dahl, 1999).  Insufficient 
overnight sleep could, in turn, interfere with pain coping skills and alter the perception of 
pain the following day (Lewin & Dahl).  Poor sleep before the onset of a pain episode 
may also be indicative of biological changes occurring that eventually cause the pain 
episode (Valrie et al., 2007a). 
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Daytime Tiredness and Fatigue  
Although one study indicates that adolescents with SCD may report less daytime 
sleepiness than those with chronic headaches (Palermo & Kiska, 2005), no research exists 
comparing patients with SCD to a non-clinical sample on measures of fatigue or 
sleepiness.  Given disruptions in overnight sleep that may occur in children with SCD as 
previously described, increased levels of daytime sleepiness may be a result of poor sleep 
quality as compared to healthy peers.  If there is an increased occurrence of sleep-
disordered breathing in children with SCD, there may be an increase in reports of 
daytime tiredness as indicated in other populations (Chervin et al., 2006; NHLBI, 2003; 
Urschitz et al., 2004). Additionally, fatigue is a known side effect of anemia in SCD 
(NHLBI, 2007; While & Mullen, 2004; Ibidapo & Akinyanju, 200l).  It has been 
suggested that fatigue may play a role in minimizing aggressiveness in boys with SCD 
and limiting social network development in girls with SCD (Noll et al., 1996).  Because 
the relationship between fatigue and quality of life in children and adolescents with SCD 
has not been studied to date, further research is necessary to understand the effects of 
fatigue on cognitive functioning and academic performance in these children. 
Nocturnal Enuresis  
Children and adolescents with SCD are more likely to exhibit nocturnal enuresis 
than age-matched controls (Barakat et al., 2001; Figueroa, Benaim, Griggs, & Hvizdala, 
1995; Jordan et al., 2005).  A review of polysomnographic data from healthy children 
with enuresis found that these children do not differ markedly from normal children in 
sleep architecture (Neveus, 2003), nonetheless, enuresis can be distressing for both the 
child and parent.   The DSM-IV-TR defines enuresis as urinating at least two times per 
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week in bed or in clothes for a minimum of three months in children of at least 5 years of 
age (American Psychiatric Association, 2000).  Two studies examined the occurrence of 
enuresis as defined by the DSM-IV, finding current clinical enuresis in 20.3%-25.4% of 
children with SCD respectively (Barakat et al.; Jordan et al.).  These rates were not 
significantly higher than sibling controls at 14.9% (Jordan et al.), but were significantly 
higher than DSM-IV estimates.  The lifetime occurrence of enuresis was significantly 
higher than sibling controls: 39.7% for children with SCD and 21.3% for siblings (Jordan 
et al.).   Enuresis occurred significantly more often in boys (28 % of males, 11% of 
females, Barakat et al.; 30% of males, 19% of females, Jordan et al.).  Parents may not 
associate enuresis with their child’s SCD and thus often report withholding fluids as a 
method of prevention of enuresis even though fluid intake is important to disease 
management, making screening for and treating enuresis with alternate methods even 
more important in SCD populations (Jordan et al.). 
 Mechanisms of increased rates of enuresis in SCD are unclear.   There has been 
speculation that renal damage due to dehydration in sickle cell results in increased fluid 
consumption and urine volume (Noll, Newman, & Gross, 1967; Saxena, Scott, & 
Ferguson, 1966).  An alternate explanation is that enuresis is caused by lower levels of 
anti-diuretic hormone (Figueroa et al., 1995).  Additionally, enuresis is a symptom of 
sleep-disordered breathing, which could also contribute to increased occurrence of 
enuresis in children with SCD (NHLBI, 2003).   
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Socioeconomic Status, Ethnic Minority Status, and Sleep 
Children with SCD in the United Sates are typically African American and an 
estimated 35% of African American children live in low-income families nationally 
(National Center for Children in Poverty, 2006), and as high as 62% live in these 
circumstances in Pennsylvania (National Center for Childhood Poverty, 2005) making 
low socioeconomic status (SES) a significant concern in this population. One study 
estimates that 59% of families with a child with SCD have incomes that qualify the 
family for some type of government assistance (Barbarin, Whitten, Bond, & Conner-
Warren, 1999).  In addition to lower SES, families of children with SCD are faced with 
many other stressors such as living in urban environments, ethnic minority status, and 
living in single-parent families (Radcliffe, Barakat, & Boyd, 2006).  These are all 
important factors to take into account when considering both health and sleep in children.   
Recently, more research has emerged addressing differences in sleep habits, 
patterns, and disorders associated with SES and ethnic minority status.  Specifically, in 
comparing an African American (n = 43) and Latino (n = 9) inner city sample of 4 to 10 
year children to normative values from middle SES Caucasian children, children of 
ethnic minority status demonstrated significantly more bedtime resistance, more sleep-
disordered breathing, and more daytime sleepiness (Daniel, Grant, Chawla, & Kothare, 
2007).   The groups did not differ significantly in sleep duration, suggesting that the 
increased incidence of daytime tiredness may be a result of reduced sleep efficiency, 
which may be affected by environmental factors that disturb sleep (i.e., co-sleeping, 
sharing rooms with family members, living in congested neighborhoods).  Parents also 
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indicated significantly more variation in nightly bedtimes, which may play an additional 
role in reduced sleep quality, and thus, increased daytime sleepiness.   
Crosby, Lebourgeois, and Harsh (2005) surveyed parents of 1,043 2 to 8 year old 
children, asking about the child’s typical nocturnal and diurnal sleep habits over the past 
month (26.5% of the sample was African American).  The results indicate that African 
American children are 6.5 times as likely to nap as Caucasian children, with 39.1% still 
napping at age 8 as compared to 4.9% of Caucasian children.  African American children 
also slept significantly less at night than Caucasian children, though groups did not differ 
on weekly sleep duration, thus, African American children most likely compensate for 
overnight sleep deficits by napping throughout the day.  The authors assert that these 
group differences are not the results of differences in demographic factors or differential 
needs for sleep by ethnic group, rather cultural differences in the caretaker’s beliefs 
regarding sleep or due to maturational differences by ethnicity (Crosby et al., 2005).    
Crabtree and colleagues (2005) used a previously validated sleep questionnaire 
(Gozal, 1998) with 973 African American and 2,398 Caucasian children ages 2-7 years 
old.  When controlling for SES and age, ethnic differences between problematic bedtime 
behavior (such as fear of sleeping in the dark, restless sleep, nighttime wakings, enuresis, 
nightmares, sleep walking/talking, and ease of falling asleep) were no longer significant.  
Ethnic differences in excessive daytime sleepiness remained, however, with African 
American parents reporting significantly more daytime sleepiness and less nighttime 
sleep in their children than Caucasian parents.  Families living in zip codes making less 
than the US average salary ($41,994) were significantly more likely to report bedtime 
behavior problems and excessive daytime sleepiness.   
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Two studies from the same research group have used the Children’s Sleep and 
Health Questionnaire (parent and child versions; Kump et al., 1994) to examine sleep 
patterns and behaviors in children and the correlates (Spilsbury et al., 2004; Spilsbury et 
al., 2006).  The first study (Spilsbury et al., 2004) administered the questionnaire to 755 
children ages 8 to 11 and their parents (35.4% ethnic minority).  Minority boys reported 
significantly less sleep than minority girls and non-minority boys and girls, and after 
controlling for demographic factors (preterm birth, caregiver education, and summer 
vacation status) minority children were 4.8 times more likely to go to bed after 11 pm 
than non-minority children.  In addition to later bedtimes and shorter sleep times, 
children of ethnic minority status also exhibit significantly more sleep-disordered 
breathing symptoms than other ethnicities studied (Spilsbury et al., 2006).  This study 
measured SES and used in home cardiorespiratory recordings to assess presence of 
obstructive sleep apnea in 843 children ages 8 to 11.  Forty children in the sample were 
diagnosed with obstructive sleep apnea and these children were significantly more likely 
to be African American, born prematurely, and also to live with a smoker, in an area of 
high poverty, and in a single parent home with a less educated caregiver.  After 
controlling for SES, obesity, and preterm birth, African American ethnicity continued to 
be significantly associated with obstructive sleep apnea. 
Other studies support the increased occurrence of sleep-disordered breathing in 
African American children as compared with primarily Caucasian controls (Redline et 
al., 1999) with one study estimating the prevalence of sleep-disordered breathing as 4 to 6 
times higher in African American children (Rosen et al., 2003).  The ethnic differences 
observed have been attributed to higher rates of preterm births and obesity in African 
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American children (Rosen et al.) and also to differences in craniofacial structure in 
African Americans as compared to Caucasians (Cakirer et al., 2001), which result in 
more snoring and obstructive sleep apnea.  Although weight would most likely not be a 
factor for children with SCD given problems with growth, the majority of children with 
SCD are African American, and thus ethnicity could be another important risk factor in 
the occurrence of sleep-disordered breathing.      
The ethnic differences in sleep habits emphasize the importance of developing 
more diverse groups when establishing normative sleep habits in children.  Given the 
minority status of most children with SCD, it is important to examine sleep habits in 
comparison to African American children without SCD to understand the contribution of 
disease status to sleep.  
 
Purpose of the Current Study  
 Previous research has detailed some of the effects of SCD on sleep (Barakat et al., 
2001; Hargrave, 2003; Valrie et al., 2007a; Valrie et al., 2007b), but there are no 
descriptive studies of general sleep practices and problems in this population.  Given the 
presence of additional risk factors of SES and minority status in SCD (Figure 1; Chervin 
et al., 2003, Crosby et al., 2005; Montgomery-Downs et al., 2003; Spilsbury et al., 2004; 
Spilsbury et al., 2006), these children may be at increased risk for inadequate sleep and 
sleep-disordered breathing.  It is important to describe the frequency of sleep disorders in 
children with SCD so that health care providers are aware of the incidence of sleep 
problems.  Also, because some sleep problems have interventions that may minimize or 
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alleviate the sleep problem (Hargrave et al., 2003; Sidman & Frye, 1988), accurate 
information can lead to improvement in the quality of life of these children.   
 The current study sought to compare children with SCD to a population of healthy 
controls from well-care clinics at the same urban hospital to understand the role of SCD 
in sleep disorders.  In addition, the study aimed to describe sleep disorders in children 
with SCD using the Children’s Sleep Habits Questionnaire (Owens et al., 2000) to 
provide preliminary values for health care providers to use as a comparison for other 
children with SCD in assessing sleep and sleep behaviors.  Improving the detection of 
sleep disorders in children with SCD could improve both quality of life and health 
outcomes, given the possible high levels of comorbidity of sleep disorders with SCD.   
Hypotheses 
Aim 1:  To describe sleep in children with SCD and evaluate rates of sleep disturbances 
in this population. 
Hypothesis 1:  It was expected that there would be significant differences in the parent 
reported Children’s Sleep Habits Questionnaire responses of parents of children with 
SCD as compared to both the validation sample for the measure and responses by an 
SES-matched comparison group. 
Hypothesis 1a:  Parents of children with SCD were expected to report more sleep-
disordered breathing in their children than both the validation sample and the 
SES-matched comparison group.   
Hypothesis 1b:  Parents of children with SCD were expected to report more 
daytime sleepiness in their children than both the validation sample and the SES-
matched comparison group.   
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Hypothesis 1c:  Parents of children with SCD were expected to report an 
increased occurrence of enuresis as compared to the validation sample and the 
SES-matched comparison group.  
Hypothesis 1d:  Parents of children with SCD were expected to report an 
increased occurrence of bedtime resistance as compared with the validation 
sample, but not as compared to the SES-matched controls.    
Aim 2:  To examine the relationship between disease severity and sleep. 
Hypothesis 2:  Disease severity was expected to predict sleep problems over and above 
the contribution of SES.   
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III.  Method 
Participants 
 Sickle cell disease group.  Parents of 67 patients (ages 4 to 10 years) of the 
Marian Anderson Sickle Cell Center at St. Christopher’s Hospital for Children completed 
the Children’s Sleep Habits Questionnaire as part of routine care during a clinic visit over 
a one-year time period (November 2004-November 2005).  Exclusion criteria for the 
current study analyses were: a history of stroke, taking hydroxyurea, receiving chronic 
transfusions, history of depression, or untreated sleep problems at the time the CSHQ was 
completed.  Two children were excluded because of a history of stroke and also receiving 
chronic transfusion, eight were excluded because of receiving chronic transfusion only, 
and three children were excluded for taking hydroxyurea.   
Parents of 54 children, ages 4 to 10, with a diagnosis of SCD comprised the final 
sample.  The hemoglobinopathies represented in the sample are HBSS (n = 28), HBSC (n 
= 22), HBSβ+ Thalassemia (n = 1), HBSβ0 Thalassemia (n = 2), and S other (n = 1). The 
children were on average 6.56 years of age (SD = 1.92) when their parents completed the 
CSHQ and 44.44% were female (n = 24).  Within the SCD group, medical chart review 
indicated that 47 children are African American, three children are Hispanic, two children 
are Caribbean, and two children are African (Table 1).    
Chart reviews indicated that 22 children (40.74%) with SCD had a concomitant 
diagnosis of Asthma  or RAD which is similar to previous research documenting 48% of 
children with SCD ever exhibiting asthma symptoms (Knight-Madden, Forrester, Lewis, 
& Greenough, 2005).   Additionally, 2 children (3.7%) had been diagnosed with 
Attention Deficit Hyperactivity Disorder and were taking stimulant medication.  The 
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average hemoglobin level before survey completion was 9.85 g/dL (SD = 1.61).  Three 
children had their tonsils and adenoids removed prior to their caregiver completing the 
CSHQ.   The average Body Mass Index for the sample was 16.95 (SD = 3.33).  The 
average disease severity score was 0.48 (SD = .74, range = 0 - 3).   The Healthcare 
Utilization Score averaged 7.27 (SD = 4.61, range: 1-17) for the year before completing 
the CSHQ.  SCD Complication Score averaged 2.21 (SD = 1.88, range: 0-7).   
Control group.  Because families of the normative sample completed the measure 
in the home and due to socio-demographic differences, there may be inherent differences 
in responses between the current study and the validation sample.  To control for effects 
of ethnicity, SES, and completing the measure in a medical setting, the results from the 
Sickle Cell Center sample were compared with an existing set of CSHQ responses also 
from parents of patients at St. Christopher’s Hospital for Children (Daniel et al., 2008).  
In the Daniel and colleagues study, parents of 52 4- to 10-year-old children completed the 
Children’s Sleep Habits Questionnaire (CSHQ) in the waiting room prior to well-care 
visits.  Children with chronic medical conditions were excluded, except for two children 
with well-controlled asthma. The children in the control group were an average of 6.71 
years of age (SD = 2.05) and 51.92% were female (n = 27).  Parents reported that 43 are 
African American, eight are Hispanic, and one child is both African American and 
Hispanic (Table 1).  The SCD group and control group did not differ significantly by 
ethnicity [Х2 (3) = 5.62, p = .132], age [t (103) = .53, p = .597], or gender [Х2 (1) = .07, p 
= .846].  
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Measures 
 Children’s Sleep Habits Questionnaire (Owens, Spirito, & McGuinn, 2000, 
Appendix A) is a 53-item parent report questionnaire regarding the last week of sleep for 
the child.  Questions about the child’s sleep and sleep behaviors are answered on the 
continuum of rarely (0-1 times per week), sometimes (2-4 times per week), or usually (5-
7 times per week) and scored from 1-3 with higher scores indicating more frequent 
problems.  The parent also indicated whether each behavior is a problem.  A sub-set of 33 
items is used to determine the Total Sleep Problems score and eight theoretically based 
subscale scores: Bedtime Resistance, Sleep Onset Delay, Sleep Duration, Sleep Anxiety, 
Night Wakings, Parasomnias, Sleep-Disordered Breathing, and Daytime Sleepiness.  
Sleep parameters such as bedtime, total sleep time, length of night wakings, and wake-
time are also assessed.   
The questionnaire generates a total scale score that demonstrated sensitivity of 
0.80 and specificity of 0.72 for differentiating between the community sample and the 
clinical sample of children with sleep disorders (Owens et al., 2000).  The CSHQ has 
demonstrated internal consistency (0.68 for the community sample and 0.78 for the 
clinical sample) and test-retest reliability (community sample only correlations for the 
subscales were from 0.62-0.79; Owens et al.).  This measure was validated in a 
predominately white middle class population, recruited from a suburban school district in 
New England (N = 469, Owens et al.).   
 Medical Chart Review.  Participants’ medical charts were reviewed to confirm 
exclusion criteria and assess disease severity through the following variables: SCD type, 
average hemoglobin/hemotocrit level over the year prior to the completion of the 
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questionnaire, acute chest syndrome in the 2 years prior to completion, pain episodes 1 
year prior to completion, and general health care utilization (hospital stays, emergency 
room visits, follow up visits, medications prescribed).  Chart review documented the 
occurrence of other medical and psychological comorbidities, such as Asthma/Reactive 
Airway Disorder (RAD), Attention Deficit Hyperactivity Disorder, and tonsil and 
adenoid removal, to possibly serve as covariates.   
 The information collected was used to complete the Sickle Cell Disease 
Assessment Instrument (Day, 2004), which uses acute chest syndrome occurrence in the 
prior 2 years and number of pain episodes in the past year requiring medical attention in a 
weighted score to determine disease severity and patient risk for SCD related 
complications.  The Healthcare Utilization Score was calculated based on the following 
information from chart reviews: summary score of hospital stays, emergency room visits, 
follow up visits, clinic visits, calls to clinic, and average hospital admittance computed 
for the year before the CSHQ was completed.  The SCD Complications score was 
calculated by combining number of pain episodes and infections requiring medical 
attention, surgeries, acute chest syndrome, MRI/TCD, asthma/RAD diagnosis, and other 
medical complications documented for one year before the CSHQ was completed.   
Socioeconomic Status.  For the SCD group, Patient zip codes were used as a 
proxy for SES.  Using the 2000 U.S. Bureau of the Census data, the average income of 
the patient’s neighborhood and average education of the zip code’s residents was used to 
estimate each patient’s SES.  The median income by zip code for the SCD group was 
$32,792.91 (SD = 12,583.87) and 23% of adults in the zip code live below the poverty 
line (SD = 12.48).  For the control group, the Hollingshead measure was completed by 
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parents (Hollingshead, 1975).  The score was computed using parent education and 
occupation.  Additionally, parents reported their annual household income.  The average 
Hollingshead score was 25.13 (range = 6-55) and the median annual income was $10,000 
- $19,900 (sample range = $0-$89,999).  Estimated income was higher for SCD group [t 
(103) = -2.27, p = .025], although both were in the $20,000-29,000 range.    
Procedure 
 Parents of all patients at the Marian Anderson Sickle Cell Center were given the 
CSHQ to complete during clinic visits, as part of routine clinical care.  All data was 
stored by number only in a password protected computer and a locked file cabinet at St. 
Christopher’s Hospital for Children to protect participant identity and private health 
information.   
Data Analysis 
Subscale analysis was conducted to assess for internal consistency using 
Cronbach’s α-coefficient.  Total Sleep Problems scores and subscale scores were 
compared within the group split by gender and genotype.  A Pearson correlation was 
conducted to examine the relationship between age and CSHQ responses.  The alpha 
level was set at .05.   
Approach to Analysis of the First Hypothesis.   The first hypothesis stated that 
parents of children with SCD will report higher total sleep problems and a greater 
occurrence of the symptoms of sleep-disordered breathing, daytime sleepiness, and 
enuresis, but not of bedtime resistance, sleep onset delay, sleep duration, or sleep anxiety 
than the validation sample and SES-matched comparison group. This was examined 
through the use of t-tests to compare the total and subscale scores of the groups.  With a p 
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value of .05 and a medium effect size, power for t-test analyses is .70 (Rosenthal & 
Rosnow, 1984).  All of the parents in the sample did not respond to each question 
regarding the sleep parameters (bedtime, waketime, length of night waking), thus, the 
power is slightly lower for these analyses.  Individual items of significantly different 
subscales were further analyzed using t-tests with a Bonferroni correction based on the 
total number of significant items.   
Approach to Analysis of the Second Hypothesis.  The second hypothesis stated 
that disease severity will be associated with the number of sleep problems reported 
beyond the contribution of SES.  Preliminary analyses examined the correlation between 
socio-demographic and disease variables with the Total Sleep Problems score and 
subscale scores.  A simultaneous multiple regression analysis was conducted with 
significant socio-demographic and disease variables as independent variables to examine 
if disease severity and SES were predictive of the total number of sleep concerns 
reported.  With a p value of .05 and a medium effect size, power for the regression is .60 
(Rosenthal & Rosnow, 1984).       
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IV. Results 
Preliminary Analyses  
Subscale analysis using Cronbach’s α-coefficient was conducted to assess for 
internal consistency with the current sample of children (Table 2).  Within the SCD 
group, alphas for the Sleep Anxiety subscale, Night wakings, and Parasomnias were 
below the acceptable range of 0.70 (Cronbach, 1951).  For the control group, Sleep 
Anxiety, Night Wakings, Parasomnias, and Daytime Sleepiness were below the 
acceptable range suggesting that these subscales should be interpreted with caution. 
Because the CSHQ is theoretically derived, the alphas tend to be less than desirable.  The 
CSHQ is widely used in research and analyzed with the eight subscales, for that reason 
subscale comparisons were conducted for all subscales but the focus for interpretation is 
on the significantly different items within the subscales. 
 Subscales, total sleep time, enuresis and Total Sleep Problems score were 
correlated with child age for each group.  Within the SCD group, age was inversely 
related to enuresis (r = -.28, p = .041), bedtime resistance behaviors (r = -.49, p = .002), 
and total sleep time (r = -.42, p = .003).  For the control group, age was not significantly 
related to any sleep variables.  Each sample was compared by gender using an ANOVA.  
Within the SCD group, parents of girls (n = 24) reported significantly more Sleep 
Anxiety (F (1, 52) = 6.58, p = .013) than parents of boys (n = 30).  All other subscales, 
Total sleep time, Total Sleep Problems score, and enuresis were not significantly 
different between genders.  Parents of girls reported significantly more fear of the dark 
and sleeping alone, however, there were no differences by gender within the control 
group. 
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Hypothesis 1:  Between group comparisons 
There were no significant differences in the sleep parameters of bedtime [F (1, 
100) = .18, p = .672], wake time [F (1, 96) = 1.75, p = .190], length of night waking [F 
(1, 92) = 2.38, p = .126], or total sleep time [F (1, 94) = .10, p = .747] between groups 
(Table 2).  Children in the SCD group had significantly more behaviors associated with 
Night Wakings [F (1, 103) = 4.22, p = .043], Sleep-disordered Breathing symptoms [F 
(1, 103) = 4.74, p = .032] and enuresis [F (1, 103) = 12.75, p = .001] than the healthy 
control group (Table 3).  All other subscales and Total Sleep Problems score were not 
significantly different between the SCD and control group.  The SCD group also had 
significantly higher scores across all CSHQ subscales and Total Sleep Problems score in 
comparison to CSHQ’s suburban, middle-class validation sample.  
An ANOVA was conducted to examine the SCD and control group differences on 
the items of the significantly different subscales, Night Wakings and Sleep-disordered 
Breathing, using a Bonferroni-corrected alpha level of 0.008.  There were no significant 
differences for the items “Moves to other’s bed in night” [F (1, 103) = 3.93, p = .05] 
“Awakens once during the night” [F (1, 103) = .21, p = .649], “Snores loudly” [F (1, 103) 
= 3.29, p = .073], or “Stops breathing” [F (1, 103) = 1.75, p = .189].  Parents of children 
in the SCD group endorsed “Awakens more than once” [F (1, 103) = 7.77, p = .006] and 
“Snorts and gasps” [F (1, 103) = 9.13, p = .003] significantly more than parents of 
children in the control group.    
Hypothesis 1a was supported by finding the parents of children with SCD 
reported more sleep-disordered breathing than the validation sample and SES-matched 
controls.  Hypothesis 1b was partially supported because parents of children in the SCD 
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group reported significantly more daytime sleepiness than the validation sample but not 
more than the SES-matched control group.  Hypothesis 1c was supported, as parents of 
children with SCD reported an increased occurrence of enuresis as compared to the 
validation sample and the SES-matched comparison group. Hypothesis 1d was supported 
as parents of children in the SCD group reported similar amounts of behaviors related to 
bedtime resistance as the control group and significantly more bedtime resistance than 
parents of children in the validation sample. 
Hypothesis 2:  Sociodemographic factors, disease severity, and sleep 
Sociodemographic factors. Pearson correlations were conducted to examine the 
relationship between sleep, demographic variables, and medical variables (Table 4).  
Percent of individuals in poverty in the patient’s zip code was significantly related to the 
Parasomnia subscale (r = .45, p = .001), the Sleep-disordered Breathing subscale (r = .29, 
p = .032), and the Total Sleep Problems score on the CSHQ (r = .38, p = .004).  The 
median income of the patients’ zip code was significantly related to the Parasomnia 
subscale (r = -.31, p = .022).  A Pearson correlation was conducted to examine the 
relationship between body mass index and parental responses to the Sleep-disordered 
Breathing subscale, the relationship was non-significant (r = -.12, p = .392). 
Disease severity.  Using genotype as a proxy of disease severity because of the 
restricted range of the Disease Severity Measure (Day, 2004), the SCD sample was split 
comparing children with the more severe genotypes HBSS/HBSβ0Thal to all other 
genotypes on sleep subscales, Total Sleep Problems score, and total sleep time using an 
ANOVA.  Parents of children with HBSS/HBSβ0Thal (n = 30) reported significantly 
more Parasomnias [F (1, 52) = 10.65, p = .002] and enuresis [F (1, 52) = 5.16, p = .027] 
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than parents of other subtypes (n = 24).  Other subscales, Total Sleep Problems score, and 
total sleep time were not significantly different by genotype.   
Using an ANOVA to compare the sample by children with and without asthma or 
RAD diagnoses according to medical chart review indicated that parents of children with 
asthma/RAD reported significantly more Bedtime Resistance [F (1, 52) = 6.97, p = .011], 
more Sleep Anxiety [F (1, 52) = 4.81, p = .033], and higher Total Sleep Problems scores 
[F (1, 52) = 5.12, p = .028].  Other subscales, total sleep time, and enuresis were not 
significantly different by group.   
Pearson correlations between subscales and disease variables were conducted to 
examine the relationship between sleep and medical factors (Table 4).  SCD 
Complications score was significantly correlated with parent report of Parasomnias (r = 
.42, p = .001), Sleep-disordered Breathing (r = .39, p = .003), and Total Sleep Problems 
score (r = .30, p = .028).  Healthcare Utilization summary score was also significantly 
related to parent endorsements of Parasomnia subscale items (r = .33, p = .016).   
In order to further elucidate the relationship of the Parasomnia subscale to the 
disease variables, enuresis, a known complication of SCD and an item on the Parasomnia 
subscale was removed.  After removing enuresis, the comparison by genotype indicated 
that parents of children with HBSS/HBSβ0Thal still reported more problems than do 
parents of other genotypes [F(1, 52) = 7.69, p = .008].   The relationship between the 
Parasomnia subscale without enuresis and Complications remained significant (r = .40, p 
= .003) as did the relationship with Healthcare Utilization (r = .31, p = .021).  [The 
Parasomnia subscale without enuresis also remained significantly related to the 
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demographic variables percent in poverty (r = .46, p < .001) and median income by zip 
code (r = -.33, p = .014) but not age (r = -.07, p = .602).] 
Predictors of sleep problems.  Based on preliminary correlations, simultaneous 
regressions were conducted to predict sleep problems for the SCD group using SCD 
Complications, Healthcare Utilization score, genotype, and Percent in Poverty as 
predictors.  Percent in Poverty was centered before being entered into the equation to 
minimize the threat of multicolinearity. The model accounted for 20.7% of the variance 
of the Total Sleep Problems score [F (4, 49) = 3.24, p = .020], with Percent in Poverty 
found to be the only significant predictor (β = .32, p = .018).  The model predicting 
restless sleep as measured by the Parasomnias subscale accounted for 38.2% of the 
variance [F (4,49) = 7.58, p < .001], and in this model, genotype HBSS/HBSβ0Thal (β = 
.32, p = .012) and Percent in Poverty were significant predictors (β = .36, p = .003). The 
model predicting Sleep-disordered Breathing accounted for 21.1% of the variance [F (4, 
49) = 3.27, p = .019], but there were no significant predictors in this model.   The 
assumptions of regression were met for each regression conducted.  Specifically, the 
assumption heteroscedasticity was examined by visually inspecting the graph of the 
residuals and the data was examined for outliers.  Hypothesis 2 was not supported in 
predicting Total Sleep Problems, Parasomnias, or Sleep-disordered Breathing in that 
disease variables did not explain the variance in sleep problems beyond the variance 
explained by demographic factors.  
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V.  Discussion 
Sleep in children with SCD has been described in some form previously, but there 
have been no studies describing the general sleep habits and behaviors of children with 
SCD and the relationship between SES, disease variables, and sleep in this population, 
although sleep has been implicated as an important factor in other childhood chronic 
illnesses. The purpose of the current study was to describe sleep habits and behaviors in a 
sample of children with SCD and to examine the contributions of SES and disease 
severity to sleep problems in these children.  A comparison group of healthy children 
from the same urban hospital were used to control for the effects of an urban environment 
and lower SES, which are known to affect sleep in other pediatric populations.  Although 
the reliability of the measure used was marginal, the Cronbach’s alphas were higher for 
the current sample than the CSHQ validation sample.   Children with SCD demonstrated 
some significant differences in sleep behaviors when compared to the SES-matched 
control group, however, disease factors were not as strongly linked to sleep as 
hypothesized.   The current findings support the need for future research to examine sleep 
as a possible contributing factor to SCD complications and as an important point for 
interventions in this population.  
Review of Results 
Parents of children with SCD reported more sleep problems across all domains 
than parents of children in the Caucasian middle class CSHQ validation sample.  
Moreover, the SCD group demonstrated similar sleep patterns and behaviors to the 
demographically matched control group, suggesting that sleep problems and behaviors 
observed in children with SCD are highly linked to socio-demographic factors.  Previous 
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research has documented the increased rate of sleep problems in children of lower SES 
(Spilsbury et al., 2004).  More specifically, children of lower SES exhibit more frequent 
sleep disruptions (Rona, Li, Guilford, & Chinn, 1998), increased reports of parasomnias 
(Stein et al., 2001), more daytime sleepiness (Crabtree et al., 2005; Stein et al., 2001), 
shorter nighttime sleep durations (Crabtree et al., 2005; Spilsbury et al., 2004), and higher 
occurrences of sleep-disordered breathing (Chervin et al., 2006; Montgomery-Downs et 
al., 2003).  Few studies on the effects of SES on sleep have examined urban, inner-city 
populations in the United States (exception: Chervin et al., 2003 in an urban community 
outside of Detroit), thus, the contribution of the inner-city environment to low SES 
exhibited in the current sample may result in further sleep problems and disruptions than 
previous studies.  Although without further controlling for other demographic factors 
(e.g., number of individuals in the home, parent education, neighborhood demographics) 
when comparing the SCD group to the normative values, exact reasons for the higher 
scores are difficult to discern.  
Sleep-disordered breathing is a significant concern for children of low SES and 
minority status.  Both the SCD group and the control group exhibited elevated levels of 
symptoms related to sleep-disordered breathing when compared with the validation 
sample.  These findings are not surprising given the multitude of risk factors for these 
children for sleep-disordered breathing such as ethnic minority status (Spilsbury et al., 
2006), living in an urban environment (Rona et al., 1998), lower SES (Spilsbury et al., 
2006), and higher rates of asthma (Redline et al., 1999).    
Behaviors associated with bedtime resistance occurred more frequently with 
families of lower SES.  Further examination of this subscale indicates that two of six 
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items may reflect co-sleeping (“falls asleep in others bed” and “needs parent in room to 
sleep”), which may be elevated in both minority families (Lozoff, Askew, & Wolf, 1996; 
Schachter, Fuchs, Bijur, & Stone, 1989) as compared to Caucasian families and also in 
families of lower income and education (Weimer et al., 2002).  The relationship of 
behaviors associated with bedtime resistance to SES likely reflects socio-cultural 
differences in parenting and bedtime practices, suggesting limitations to using a 
questionnaire developed with a population of vastly different demographics.   
Daytime sleepiness also appears to be related to SES but not disease status as 
hypothesized.  Children in the current sample and the control sample may exhibit more 
disrupted sleep and, thus, daytime tiredness due to reduced sleep efficiency and sleep 
quality overnight, because of environmental factors, such as sharing a room or bed, 
family members with different schedules that may disrupt the child’s sleep, or living in a 
densely populated area with sufficient ambient noise to disrupt sleep.  Without further 
information regarding the home and sleeping environment, this remains speculation.  
There were no differences in total sleep time between the three groups, but parents of the 
SES-matched control group and the SCD group reported significantly more tiredness in 
their children than the CSHQ validation sample.  Previous research suggests that parents 
of children of ethnic minority status report more daytime tiredness but also reduced 
nighttime sleep (Crabtree et al., 2005), contrary to the current findings of similar amounts 
of overnight sleep between groups.  Demographic variables were not related to parent 
reports of daytime tiredness in either the SCD group or the control group, possibly due to 
the restricted range in SES within each group.   
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Furthermore, SES appears to make a substantial contribution to parent reported 
sleep problems within the SCD group.  Using zip codes as a proxy for SES, as employed 
in prior research (Spilsbury et al., 2006), the percent of individuals below the poverty line 
in patients’ zip codes were moderately related to the subscales Bedtime Resistance, 
Parasomnias, and Sleep-disordered Breathing as well as the Total Sleep Problems 
reported.  In the regression models, percent below the poverty line was a significant 
predictor of Parasomnias and Total Sleep Problems score predicting a larger portion of 
the variance than disease related predictors.  Although it is unclear how percent in 
poverty and sleep problems are directly related in the SCD sample, environmental factors 
that affect the child’s sleeping environment may drastically affect sleep quality and, in 
turn, daytime tiredness and health outcomes.  Although highly correlated with one 
another, median income of the patients’ zip codes was not related to as many sleep 
variables as percent of individuals in poverty.  It is possible that the percentage of 
individuals living below the poverty line is more indicative of the kind of neighborhood 
distress that may affect the child’s environment than income or that it is a more reliable 
indicator of poverty.   
Although sociodemographic factors significantly affect sleep in children with 
SCD, disease factors cannot be ignored when assessing sleep in these children.  Results 
indicate that there are some differences between children with SCD and demographically 
matched controls suggesting a unique contribution from SCD beyond SES.  The literature 
consistently supports higher rates of nocturnal oxyhemoglobin desaturation (Franco et al., 
1996; Samuels et al., 1993; Setty et al., 2003), sleep-disordered breathing (Kaleyias et al., 
2008; Samuels et al., 1993), and enuresis (Barakat et al., 2001; Figueroa et al., 1995; 
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Jordan et al., 2005) in children with SCD.  Research on daytime sleepiness in these 
children is sparser, although there are several overnight sleep problems, such as sleep-
disordered breathing (Kaleyias et al., 2008) and hypoxemia (Samuels et al., 1993), in this 
population that likely disrupt sleep and affect sleep efficiency leading to poor sleep 
quality.  Pain also plays a significant role in disrupting overnight sleep, with some 
research suggesting a cyclical relationship between pain and sleep quality (Valrie et al., 
2007b).  
The composite score of Healthcare Utilization was moderately correlated with 
parent reports of restless sleep as measured by the Parasomnia subscale.  Disease 
processes that result in more infections and pain episodes may lead to more disrupted 
sleep in children with SCD.  There were small but significant correlations between the 
SCD Complications score and the subscales Sleep Onset Delay, Parasomnias, and Sleep-
disordered Breathing.  The contribution of disease factors to sleep problems is limited to 
information reported in the medical chart which may be influenced by family 
relationships with healthcare providers, healthcare beliefs, healthcare efficacy, and other 
individual factors that influence reports of pain and complications to healthcare staff.   
As predicted, parent reports on the Sleep-disordered Breathing subscale were 
significantly higher in the SCD group than either the SES-matched control group or the 
validation sample.  The alpha for this subscale was significantly higher in the SCD group 
as compared to the controls and the validation sample, suggesting that these items are 
more relevant to a SCD population.  These findings imply that although SES and sleep-
disordered breathing are often highly related (Chervin et al., 2006; Montgomery-Downs 
et al., 2003), SCD may contribute to the incidence of sleep-disordered breathing beyond 
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contributions of SES.  It is likely that there are different mechanisms resulting in sleep-
disordered breathing for each of these groups.  Obesity is a significant contributing factor 
to the increased occurrence of sleep-disordered breathing in children of lower socio-
economic means; however obesity is not a concern for children with SCD due to their 
tendency to be underweight.  The average body mass index of children in the SCD group 
did not indicate that children were overweight and body mass index was unrelated to 
parent reports of sleep-disordered breathing in the SCD sample, suggesting that breathing 
difficulties overnight are not related to overweight status.   
Sleep-disordered breathing likely occurs more frequently in children with SCD 
due to andenotonsillar hypertrophy or possibly because of chronic lung disease, which is 
far less common (Bandla & Splaingard, 2004). Interestingly, within the SCD group, 
parent reported Sleep-disordered Breathing subscale responses did not differ between 
groups of children with an asthma/RAD diagnosis and those without an asthma/RAD 
diagnosis, suggesting that parent reported sleep-disordered breathing is independent of 
other preexisting pulmonary problems. To further understand the contributions of 
environmental, genetic, and disease related factors to sleep-disordered breathing in 
children with SCD, future studies should assess familial occurrence of sleep-disordered 
breathing, as well as environmental factors (e.g. allergies, allergens in the home).   
Night wakings were more frequent in children with SCD as compared to SES-
matched controls.  It should be considered, however, that there is a low alpha for this 
subscale, suggesting that the subscale items may not be assessing the same construct.  
Only the item “Awakens more than once per night” was significantly higher in the SCD 
group, which may be due to increased need to urinate, enuresis, pain, or other disease 
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related factors.  Additionally, the item “Child returns to sleep without help after waking” 
not included in the Night Waking subscale, may further elucidate the nature of the night 
waking.  Although there is not a comparison for the item in the normative data or the 
control group because it is part of the expanded questionnaire, parent responses for the 
SCD group indicated that children sometimes (13%) or usually (59.3%) return to sleep.  
This item was not correlated with enuresis, suggesting that children are waking for other 
reasons possibly to use the restroom or because of pain.  Another possible cause of night 
waking theorized for children with SCD is the occurrence of disease processes, such as 
lower oxygen levels that is a precursor to a pain episode the following day, disrupting 
sleep and reducing sleep efficiency (Valrie et al.  2007a).  Understanding the cause of 
night wakings is important because interventions could be implemented to reduce 
wakings and help the child increase sleep efficiency and sleep quality, which could help 
reduce daytime tiredness.  For future research it is important to use sleep diaries to 
monitor night waking frequency and causes.   
 As predicted, parents of children in the SCD group reported significantly greater 
frequency of enuresis than either the control group or the CSHQ validation group values.  
Child age was inversely correlated with parent reports of enuresis, with older children 
wetting the bed less often.  There are a few possible mechanisms of increased enuresis in 
SCD: kidney damage may affect urine volume coupled with increased fluid intake to 
prevent dehydration resulting in more frequent bedwetting (Noll et al., 1967; Saxena et 
al., 1966) and/or children may have lower levels of anti-diuretic hormone (Figueroa et al., 
1995).  Another possible cause of enuresis could be the increased occurrence of sleep-
disordered breathing in this population.  Enuresis occurs more frequently in children with 
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sleep-disordered breathing due to changes in intrathoracic pressure as a result of 
paradoxical breathing episodes during apnea events.  Changes in pressure around the 
heart brought on by labored breathing and negative air pressure can cause the heart to 
secrete hormones that increase the excretion of sodium and water, resulting in an 
increased need to urinate (for a review see Umlauf & Chasens, 2003).  The moderate 
correlation between the Sleep-disordered Breathing subscale and enuresis suggest that 
enuresis in children with SCD may also be related to higher rates of sleep-disordered 
breathing in this population.  
The percentage of children in the SCD group to “usually” wet their bed is similar 
to previous research (current sample = 18 %) with prior estimates between 20-25% 
(Barakat et al., 2001; Jordan et al., 2005).  Combining the groups of children who 
“usually” and “sometimes” wet their bed in the current sample yielded a higher rate of 
enuresis than previous studies (37%).  This higher rate could be explained by the larger 
age ranges used in previous samples (Barakat et al., range = 5 – 22, average age = 11.92; 
Jordan et al., range = 5 – 17, average age = 10.90).  Previous studies also used a 
structured interview to assess enuresis, while the current study utilized only one item.  It 
is unclear whether parent reports of “sometimes wets the bed” indicate a current behavior 
or one that occurred in the recent past.  Additional questions should be included with the 
CSHQ to describe the frequency and the most recent occurrence of enuresis.  
Children with more severe forms of SCD (HBSS/HBSβ0Thal) exhibit more 
restless sleep and enuresis as compared to the less severe disease types, suggesting that 
disease severity plays a roll in disrupting sleep.  Restless sleep, as measured by the 
Parasomnia subscale, was not a unitary construct as indicated by the subscale’s alpha.  
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The items on the Parasomnia subscale ask about enuresis, night terrors, sleep walking, 
bruxism, and generally restless sleep.  The item “Restless and moves a lot” was not 
different between the SCD group and control group; however within the SCD group, 
parents of children with more severe genotypes endorsed this item more frequently than 
parents of children with more mild genotypes.  Restless sleep may be a result of disease 
processes disrupting sleep prior to the onset of pain episodes (Valrie et al., 2007a) or 
given the similar amounts reported between the SCD group and control group, restless 
sleep could be related to SES.  Poor sleep quality is related to increased occurrence of 
pain the following day in children with SCD (Valrie et al., 2007a).  Directionality 
between sleep quality/restless sleep and pain remains unclear, although results that 
restless sleep is more common in children with more severe types of SCD may support 
theories that disease processes affect sleep rather than poor sleep as causing disease 
complications.  The pain literature suggests that nocturnal pain disrupts sleep, results in 
reduced stage N-3 sleep (deep sleep), and can modify pain sensitivity (see Onen et al., 
2005 for a review).  More recent research based on pain and sleep diaries supports a 
cyclical relationship between pain and sleep (Valrie et al., 2007a).  Pain may be more 
difficult to tolerate in the face of reduced sleep quality and quantity (Lewin & Dahl, 
1999) or pain thresholds may be lowered by poor sleep (Onen et al., 2004), possibly 
leading to patient perceptions of more severe pain following poor sleep and to poorer 
coping responses to pain.  
A moderate amount of the variance in parent reported restless sleep, as indicated 
by the Parasomnia subscale was explained by genotype, percent in poverty, SCD 
Complications, and Healthcare Utilization. Using the same predictors, the models 
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predicting Total Sleep Problems score and the Sleep-disordered Breathing subscale 
accounted for a smaller portion of the variance.   The smaller portion of the variance 
explained by these models suggests that disease severity plays a lesser role in sleep-
disordered breathing and overall sleep problems.  Possibly, sleep-disordered breathing is 
exacerbated by earlier episodes of SCD complications leading to adenotonsillar 
hypertrophy that are not within the one year time frame sampled here.    When 
controlling for SES, disease severity as indicated by genotype, was a significant predictor 
of parent reported sleep behaviors on the Parasomnia subscale; however, other measures 
of disease severity were not significant predictors of either Total Sleep Problems score or 
the Sleep-disordered Breathing subscale.  This provides limited support for the second 
hypothesis.   
  A common complication of children with SCD, asthma/RAD, was also used to 
split the sample.  These parents report more bedtime behavior problems (bedtime 
resistance and sleep anxiety) and overall sleep problems than parents of children without 
an asthma/RAD diagnosis.    Interestingly, some medications used to treat asthma/RAD 
have stimulating properties and thus, may be related to problems with bedtime routines 
and sleep onset in these children (Stores, Ellis, Wiggs, Crawford, & Thomson, 1998).  
More information is needed about dosing practices to support the hypothesis that 
stimulant medication is contributing to children being more resistant at bedtime.  Other 
research indicates that children with asthma exhibit more frequent night wakings, shorter 
sleep times, and reduced stage N-3 sleep, all of which are correlated with severity (Sadeh 
et al., 1998).  Because asthma symptoms often worsen during the night due to circadian 
variations in pulmonary flow rates (for a review see Bandla & Splaingard, 2004), 
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children could possibly resist bedtime due to previous experience with the nocturnal 
worsening of symptoms.  Bedtime resistance could reflect the child learning to dislike 
sleep because it is physically uncomfortable and distressing.  Clinically, healthcare 
providers should educate families about the timing of medications to avoid disrupting 
sleep in these children, while also maximizing the effects of the medications to extend 
throughout the night.   
The increased occurrence of night wakings, sleep-disordered breathing, and 
enuresis in children with SCD as compared to controls indicates that SCD does play a roll 
in disrupting sleep in children.  Furthermore, the increased occurrence of restless sleep in 
children with more severe genotypes plus bedtime resistance and sleep anxiety in 
children with concomitant asthma/RAD diagnoses suggests that children with SCD are at 
risk for a variety of sleep problems that may affect disease status.  Although socio-
demographic factors appear to be the bigger risk factor for poor sleep habits and quality, 
the impact of SCD cannot be ignored in patients with SCD.   
Limitations  
The current study is limited in its small convenience sample and cross-sectional 
nature that does not allow for the bidirectional assessment of the relationship between 
sleep and disease severity.  Within the SCD group, a larger sample size with more 
representativeness across genotypes could have allowed for more group differences to be 
detected regarding disease severity and sleep.  The sample was primarily HBSS and 
HBSC, making it difficult to detect relationships between genotype and sleep among 
other disease types.   
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The current data only allows for the assessment of sleep as an outcome of disease 
problems, although disrupted sleep may be a precursor to complications.   The study is 
also limited in its use of subjective parent reports of sleep behaviors without objective 
measures of sleep to corroborate parent reports (e.g. actigraphy, polysomnography).  
Objective reports would prove especially important for assessing behaviors such as night 
waking, for which parents are not always aware.  Also, because of the parent report data 
indicating retrospective sleep behaviors and habits, it is difficult to assess closely the 
daily relationship between disease severity and pain.  Questionnaire responses may also 
be subject to report biases.  The retrospective questionnaire is important for clinical use 
as the CSHQ is an easily administered tool that allows healthcare providers to frequently 
track the child’s sleep habits during routine clinical care.  More demographic information 
(e.g. single parent status, parent education) on the validation sample and the SCD sample 
would allow for further analysis of specific demographic factors’ contribution to sleep 
problems.  Future use of the CSHQ with children with SCD should assess causes of night 
wakings, co-sleeping and/or sharing a room, the child’s sleep environment (e.g. noise, 
television), and the last episode of enuresis.         
Psychometrically, the alphas on some of the subscales of the CSHQ are less than 
desirable.  Because this is a theoretically derived questionnaire, based on clinical work 
with a demographically disparate population, not all subscales are representative of the 
initial construct conceptualized by the authors.  Interestingly, the alphas are generally 
higher in the SCD group than the SES-matched control group and the CSHQ validation 
sample, suggesting that the items may be more closely related in this population as 
compared to generally healthy control children.  This difference is especially pronounced 
45  
on the Sleep-disordered Breathing subscale, with a difference in alpha’s between groups 
of .37.   
General Conclusions and Future Directions 
The current study described sleep habits and behaviors in children with SCD as 
compared to a demographically matched control group and middle class suburban 
Caucasian group.  Children with SCD demonstrate significantly more sleep problems 
across the board than middle-class Caucasian children.  The differences between children 
with SCD and the demographically matched control group were less pronounced, 
suggesting that many problematic sleep patterns and behaviors are exacerbated by lower 
SES, living in an urban environment, and minority status.  The hypotheses comparing 
children with SCD to the SES-matched control were generally supported, except for 
similar levels of daytime sleepiness and higher levels of night waking in children with 
SCD.  This pattern of results suggests that socio-demographic factors are important 
determinants of sleep behaviors and quality in children.  Within the SCD sample, SES 
was more highly related to sleep problems than most disease factors.  It is possible that 
disease factors are better used as outcome measures than predictors of sleep problems, 
possibly refuting the assertion by previous research that there is a bidirectional 
relationship between sleep and disease processes in children with SCD.    
Because sleep problems may minimize the child’s ability to cope with SCD and 
its complications, both physiologically and psychologically, it is important for health care 
practitioners to routinely screen children for sleep problems during regular healthcare 
appointments.  Referrals should be made for children with SCD to see sleep specialists 
when warranted, especially in cases with sleep-disordered breathing, which may result in 
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further disease complications.  During SCD hospital follow-up visits, healthcare 
providers should ask parents and older children about sleep quality before pain episodes 
to assess patterns that precede pain episodes and help caregivers intervene with palliative 
methods earlier. Lastly, it is important to work with caregivers to modify the sleeping 
environment and sleep hygiene (e.g. removing the television from the bedroom, using a 
white noise maker to drown out ambient noise) so as to maximize sleep efficiency and 
sleep quality for children. 
Future research should address sleep in children with SCD using objective and 
subjective reports in concert to describe sleep habits and behaviors in these children.  
Other predictors of sleep problems should also be examined within this population to 
better understand the causes of sleep disruptions in children with SCD.  Additionally, 
studies should examine the pain and sleep connection more closely using prospective 
measures and diaries.  Research addressing the long-term effects of sleep on disease 
outcomes and general health are essential next steps.  Finally, intervention studies are 
important for children with SCD, specifically focusing on modifying sleep behaviors and 
sleep problems in relation to their effects on disease outcome.  
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Figure 1.  Sleep and Sickle Cell Disease Model.   
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Table 1.  Demographics, Sleep Parameters, and Disease Characteristics. 
 
 SCD Group 
N = 54 
SES-Matched Control Group 
N = 52 
Variable N (%) M (SD) N (%) M (SD) 
 
Age 
 
  
6.56 (1.92) 
  
6.71 (2.05) 
Gender (% female) 
 
24 (44.44)  27 (51.92)  
Ethnicity 
 
    African American 
 
    Latino 
 
    Caribbean 
 
    African 
 
    African American    
    &  Hispanic 
 
 
 
47 (87.03) 
 
3 (5.56) 
 
2 (3.70) 
 
2 (3.70) 
 
-------- 
  
 
43 (82.69) 
 
8 (15.38) 
 
------- 
 
-------  
 
1 (1.92) 
 
Sleep Parameters 
 
Total Sleep Time (hr) 
 
  
 
9.97 (1.93) 
  
 
9.85 (1.91) 
Average Bedtime (PM) 
 
 8:55 (00:53)  8:51 (00:36) 
Average Waketime (AM) 
 
 7:14 (00:52)  6:59 (01:01) 
Length of Wakings (min) 
 
 11.39 (21.66)  5.92 (12.10) 
Disease Variables 
 
Hemoglobin 
 
Healthcare  Utilization 
 
SCD Complications 
   
 
9.85 (1.61) 
 
7.27 (4.61) 
 
2.21 (1.88) 
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Table 2.  Subscale and Total Sleep Problems score Cronbach’s alphas by group. 
 
Scale SCD Group 
N = 54 
Control Group 
N = 52 
Total Sample 
N  = 106 
Bedtime Resistance 
 
.78 .75 .77 
Sleep Duration 
 
.79 .74 .77 
Sleep Anxiety 
 
.59 .53 .57 
Night Wakings 
 
.38 .46 .44 
Parasomnias 
 
.50 .45 .47 
Sleep-disordered 
Breathing 
 
.80 .43 .71 
Daytime Sleepiness 
 
.69 .52 .61 
Total Sleep 
Problems score* 
 
.85 .69 .80 
* Total Sleep Problems score alphas are computed for core 33 items.   
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Table 3.  Subscale comparisons. 
 
 
 
Urban 
Control 
SCD 
Group 
Validation 
Sample 
Bedtime Resistance 
 
8.86 8.89
* 
7.06
*
 
Sleep Onset Delay 
 
1.49 1.52
*
 1.25
*
 
Sleep Duration 
 
3.98 4.18
*
 3.41
*
 
Sleep Anxiety 
 
5.10   5.54
*
 4.89
*
 
Night Wakings 
 
3.92
+
 4.42
+*
 3.51
*
 
Parasomnias 
 
8.41 8.83
*
 8.11
*
 
Sleep-disordered Breathing 
 
3.70
+ 
4.33
+*
 3.24
*
 
Daytime Sleepiness 
 
14.25 13.42
*
 9.64
*
 
Total Sleep Problems score 47.02 48.67
*
 38.84
*
 
 
+ 
p < .05 between Urban Control and SCD Group 
* p < .05 between Validation Sample and SCD Group
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Table 4.  Correlation between demographics, disease variables, and sleep variables.   
 
 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1.  Age 
 
0.07 -0.09 -0.03 0.25 0.11 -0.28* -0.40** -0.20 -0.16 -0.19 0.05 -0.17 -0.20 0.04 -0.22 -0.40** 
2.  Percent in poverty 
 
 -0.91**  0.18 0.01 0.29* 0.19 0.29* 0.23 0.20 0.25 0.18 0.45** 0.29* 0.13 0.38**  0.17 
3.  Median Income 
 
  -0.08 0.01 -0.16 -0.10 -0.24 -0.17 -0.19 -0.20 -0.17 -0.31* -0.13 -0.05 -0.26 -0.10 
4.  Healthcare Utilization  
 
  0.31** 0.73** 0.18 0.16 0.12 0.01 0.18 0.08 0.33* 0.25 0.01 0.18  0.09 
5.  Disease Severity 
 
    0.43** -0.11 -0.09 0.15 -0.13 -0.08 -0.00 -0.07 -0.02 -0.24 -0.16  0.02 
6.  Complications 
 
     0.24 0.20 0.24* 0.03 0.17 0.08 0.42** 0.39** 0.12 0.30*  0.15 
7.  Enuresis 
 
      0.08 0.14 -0.07 -0.09 0.07 0.62** 0.36** 0.18 0.28*  0.29* 
8.  Bedtime Resistance  
 
      0.13 0.48* 0.79** 0.40** 0.40** 0.37** 0.16 0.71**  0.18 
9.  Sleep Onset Delay 
 
        0.27* 0.05 0.02 0.29* 0.13 0.33* 0.37** -0.05 
10.  Sleep Duration 
 
         0.45** 0.44** 0.16 0.09 0.29* 0.60** -0.08 
11.  Sleep Anxiety 
 
          0.38** 0.25 0.26 0.19 0.63**  0.05 
12.  Night Wakings 
 
           0.21 0.10 0.18 0.49** -0.07 
13. Parasomnias 
 
            0.66** 0.35** 0.68**  0.18 
14.  SDB 
 
             0.41** 0.66**  0.24 
15.  Daytime Sleepiness 
 
              0.70** -0.29* 
16.  Total Sleep Problems   
 
                0.00 
17. Total Sleep Time 
 
                
*
p < .05, 
**
p <.01
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Appendix C. 
Child’s Sleep Habits 
(Preschool and School-Aged) 
 
The following statements are about your child’s sleep habits and possible difficulties  
with sleep.  Think about the past week in your child’s life when answering the questions.   
If last week was unusual for a specific reason (such as your child had an ear infection and  
did not sleep well or the TV set was broken), choose the most recent typical week.  Answer 
USUALLY if something occurs 5 or more times in a week; answer SOMETIMES if it  
occurs 2-4 times in a week; answer RARELY if something occurs never or 1 time during 
 a week.  Also, please indicate whether or not the sleep habit is a problem by circling “Yes, 
” “No,” or “Not applicable (N/A). 
 
Bedtime 
Write in child’s bedtime: _______________ 
 
       3      2  1   Problem? 
                   Usually     Sometimes    Rarely 
                        (5-7)     (2-4)          (0-1)      
 
Child goes to bed at the same time at night (R)(1) □      □  □      Yes  No  N/A 
Child goes to bed at the same time at night (R) (1) □      □  □      Yes  No  N/A 
Child falls asleep within 20 minutes after going 
 to bed (R)(2)     □      □  □      Yes  No  N/A 
Child falls asleep alone in own bed (R)(3)  □      □  □      Yes  No  N/A 
Child falls asleep in parent’s or sibling’s bed (4) □      □  □      Yes  No  N/A 
Child falls asleep with rocking or rhythmic  
 movements      □      □  □      Yes  No  N/A 
Child needs special object to fall asleep 
 (doll, special blanket, etc.)   □      □  □      Yes  No  N/A 
Child needs parent in the room to fall asleep (5) □      □  □      Yes  No  N/A 
Child is ready to go to bed at bedtime  □      □  □      Yes  No  N/A 
Child resists going to bed at bedtime   □      □  □      Yes  No  N/A 
Child struggles at bedtime (cries, refuses to stay 
 in bed, etc.) (6)    □      □  □      Yes  No  N/A 
Child is afraid of sleeping in the dark (7)  □      □  □      Yes  No  N/A 
Child is afraid of sleep alone (8)   □      □  □      Yes  No  N/A 
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Sleep Behavior 
Child’s usual amount of sleep each day:  _________ hours and __________ minutes (combining 
nighttime sleep and naps) 
        
3      2  1   Problem? 
                   Usually     Sometimes    Rarely 
                        (5-7)     (2-4)          (0-1)      
 
Child sleeps too little (9)    □      □  □      Yes  No  N/A 
Child sleeps too much    □      □  □      Yes  No  N/A 
Child sleeps the right amount (R) (10)  □      □  □      Yes  No  N/A 
Child sleeps about the same amount     
 each day (R)(11)    □      □  □      Yes  No  N/A 
Child wets the bed at night    □      □  □      Yes  No  N/A 
Child talks during sleep (13)    □      □  □      Yes  No  N/A 
Child is restless and moves a lot during sleep (14) □      □  □      Yes  No  N/A 
Child sleepwalks during the night (15)  □      □  □      Yes  No  N/A 
Child moves to someone else’s bed during 
 the night (parent, brother, sister, etc.) (16) □      □  □      Yes  No  N/A 
Child reports body pains during sleep.  If so, where?□      □  □      Yes  No  N/A 
 ________________________________ 
Child grinds teeth during sleep (your dentist may 
 have told you this) (17)   □      □  □      Yes  No  N/A 
Child snores loudly (18)    □      □  □      Yes  No  N/A 
Child seems to stop breathing during sleep (19) □      □  □      Yes  No  N/A 
Child snorts and/or gasps (20)   □      □  □      Yes  No  N/A 
Child has trouble sleeping away from home  
 (visiting relatives, vacation) (21)  □      □  □      Yes  No  N/A 
Child complains about problems sleeping   □      □  □      Yes  No  N/A 
Child awakens during night screaming, sweating,  
and inconsolable (22)    □      □  □      Yes  No  N/A 
Child awakens alarmed by a frightening dream □      □  □      Yes  No  N/A 
 
Waking During the Night 
 
       3      2  1   Problem? 
                   Usually     Sometimes    Rarely 
                        (5-7)     (2-4)          (0-1)      
Child awakes once during the night (24)  □        □  □      Yes  No  N/A 
Child awakes more than once during the night (25)   □      □  □      Yes  No  N/A 
Child returns to sleep without help after waking □      □  □      Yes  No  N/A 
 
Write the number of minutes a night waking usually lasts:  ______________________________ 
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Morning Waking 
 
Write in the time of day child usually wakes in the morning:  ____________________________ 
 
       33      2  1   Problem? 
                   Usually     Sometimes    Rarely 
                        (5-7)     (2-4)          (0-1)      
 
Child wakes up by him/herself (R)   □      □  □      Yes  No  N/A 
Child wakes up with alarm clock   □      □  □      Yes  No  N/A 
Child wakes up in negative mood (27)  □      □  □      Yes  No  N/A 
Adults or siblings wake up child (28)   □      □  □      Yes  No  N/A 
Child takes a long time to become alert in  
 the morning (30)    □     □  □      Yes  No  N/A 
Child wakes up very early in the morning  □     □  □      Yes  No  N/A 
Child has a good appetite in the morning  □     □  □      Yes  No  N/A 
 
Daytime Sleepiness 
 
       3      2  1   Problem? 
                   Usually     Sometimes    Rarely 
                        (5-7)     (2-4)          (0-1)      
Child naps during the day    □     □  □      Yes  No  N/A 
Child suddenly falls asleep in the middle of  
active behavior    □     □  □      Yes  No  N/A  
Child seems tired (31)    □     □  □      Yes  No  N/A 
 
During the past week, your child has appeared very sleepy or fallen asleep  
during the following (check all that apply): 
 
   1  2  3 
      Not Sleepy     Very Sleep     Falls Asleep 
 
Playing alone            □  □  □       
Watching TV (32)     □             □  □       
Riding in car (33)      □  □  □       
Eating meals           □  □  □       
 
 
 
Scoring: 
Items with (R) are reverse scored.   
Items with (number) are included in subscales and Total Sleep Problems score.   
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